Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2
Get every episode summarized
Each time Two Onc Docs publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Today’s episode is an update on AML (acute myeloid leukemia). In Part 2 we discuss the treatment options for first-line, as well as relapsed/refractory disease. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at UPenn.
Get every episode summarized
Each time Two Onc Docs publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Two Onc Docs
Breast Cancer Screening, Prevention & Intro 2026 UPDATE
Two Onc Docs
ctDNA & MRD: Current Applications, Limitations & What’s Next
Two Onc Docs
ctDNA, Liquid Biopsies, Methylation, NGS: What Does It All Mean?
Two Onc Docs
Metastatic Non-Small Cell Lung Cancer 2026 UPDATE
Two Onc Docs